Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
Neuroradiology
|
January 1, 1993
Database for serial magnetic resonance imaging in multiple sclerosis
F Barkhof, A J Thompson, L Kappos, et al.
Neurology
|
November 27, 2002
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS
M Clanet, E W Radue, L Kappos, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 14, 2017
A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis
M S Freedman, J S Wolinsky, P Truffinet, et al.
Lancet (London, England)
|
August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group
L Kappos, D Moeri, E W Radue, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS)
B O Khatri, J Pelletier, L Kappos, et al.
European Journal of Neurology
|
October 26, 2005
Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis
C Weder, G M Baltariu, K A Wyler, et al.
European Neurology
|
January 25, 2014
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study
M Doerner, K Beckmann, V Knappertz, et al.
Neurology
|
September 27, 2006
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
L Kappos, A Traboulsee, C Constantinescu, et al.
Brain : a Journal of Neurology
|
June 16, 2001
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment
F Barkhof, J H van Waesberghe, M Filippi, et al.
Neurology
|
November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS
J Kuhle, R Gosert, R Bühler, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
Neuroradiology
|
January 1, 1993
Database for serial magnetic resonance imaging in multiple sclerosis
F Barkhof, A J Thompson, L Kappos, et al.
Neurology
|
November 27, 2002
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS
M Clanet, E W Radue, L Kappos, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
June 14, 2017
A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis
M S Freedman, J S Wolinsky, P Truffinet, et al.
Lancet (London, England)
|
August 25, 1999
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group
L Kappos, D Moeri, E W Radue, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS)
B O Khatri, J Pelletier, L Kappos, et al.
European Journal of Neurology
|
October 26, 2005
Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis
C Weder, G M Baltariu, K A Wyler, et al.
European Neurology
|
January 25, 2014
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND study
M Doerner, K Beckmann, V Knappertz, et al.
Neurology
|
September 27, 2006
Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS
L Kappos, A Traboulsee, C Constantinescu, et al.
Brain : a Journal of Neurology
|
June 16, 2001
T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment
F Barkhof, J H van Waesberghe, M Filippi, et al.
Neurology
|
November 15, 2011
Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS
J Kuhle, R Gosert, R Bühler, et al.
Page
of 23